U.S. markets closed

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4800-1.9800 (-30.65%)
At close: 04:00PM EDT
4.4600 -0.02 (-0.45%)
After hours: 07:57PM EDT

Co-Diagnostics, Inc.

2401 South Foothill Drive
Suite D
Salt Lake City, UT 84109
United States
801 438 1036

IndustryMedical Devices
Full Time Employees101

Key Executives

NameTitlePayExercisedYear Born
Mr. Dwight H. EganChairman, CEO & Pres1.02MN/A1953
Mr. Brian L. Brown CPACFO & Company Sec.730.62kN/A1976
Mr. Reed L. BensonGen. Counsel385.85kN/A1948
Dr. Brent C. Satterfield Ph.D.Co-Founder & Member of Scientific Advisory BoardN/AN/A1977
Dr. Jesse MontgomeryChief Scientific OfficerN/AN/AN/A
Mr. Andrew BensonHead of Investor RelationsN/AN/AN/A
Dr. Mayuranki AlmaulaSr. VP of Overseas Operations & Strategic AlliancesN/AN/AN/A
Mr. Cameron GundryHead of Commercialization LATAM/EURN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Co-Diagnostics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.